Zealand Pharma A/S
Peptide conjugates of GLP-1 receptor agonists and gastrin and their use

Abstract:

The present invention relates, inter alia, to certain peptide conjugates, and to the use of the conjugates in the treatment of a variety of diseases or disorders, including diabetes (type 1 and/or type 2) and diabetes related diseases or disorders.